Published: July 16, 2021 | Tags: Eli Lilly, Banner Alzheimer’s Institute, Donanemab, P-III, TRAILBLAZER-ALZ 3 Trial, Alzheimer Disease
Published: July 16, 2021 | Tags: AcelRx, License Agreement, Aguettant, Dzuveo, EU, Pre-Filled Syringe Products, US
Published: July 16, 2021 | Tags: Bio-Thera, P-III, BAT2206, Proposed Biosimilar, Stelara, Ustekinumab
Published: July 16, 2021 | Tags: Vir, P-II, MARCH Trial, VIR-2218, VIR-3434, Functional Cure Regimen, Chronic Hepatitis B Virus Infection
Published: July 16, 2021 | Tags: Alexion, Ultomiris, ravulizumab-cwvz, P-III, Study, Generalized Myasthenia Gravis
Ipsen Signs an Exclusive WW License Agreement with IRLAB for Mesdopetam to Treat Parkinson Disease
Published: July 16, 2021 | Tags: Ipsen, License Agreement, IRLAB, Mesdopetam, Parkinson Disease
Published: July 15, 2021 | Tags: Skyhawk, Aragen, Develop, Novel Small Molecule Therapeutics
Published: July 15, 2021 | Tags: Heat Biologics, ProBioGen, Transposase System, Suspension, HEK293 Cell Line
Published: July 15, 2021 | Tags: Johnson & Johnson, Single-Shot COVID-19 Vaccine, P-I/IIa, Sub-Study, COVID 19, NEJM
Published: July 15, 2021 | Tags: Novartis, Incyte, Jakafi, ruxolitinib, P-III, REACH3 Study, Chronic Graft-Versus-Host Disease, NEJM
Galapagos Reports Results of GLPG3667 in P-Ib Study for the Treatment of Psoriasis
Published: July 15, 2021 | Tags: Galapagos, GLPG3667, P-Ib, Study, Psoriasis
Eli Lilly to Acquire Protomer Technologies for ~$1B
Published: July 15, 2021 | Tags: Eli Lilly, Acquire, Protomer Technologies, ~$1B
Published: July 14, 2021 | Tags: Caribou, First Patient Dosing, P-I, ANTLER Trial, CB-010, B- Cell Non-Hodgkin Lymphoma
Published: July 14, 2021 | Tags: Strongbridge, Post Hoc Analyses, One Year, HYPHOP Study, Keveyis, dichlorphenamide, Primary Periodic Paralysis
Published: July 14, 2021 | Tags: Astellas, License Agreement, ExCellThera, In Vitro, UM171, Pluripotent Stem Cells
Published: July 14, 2021 | Tags: Ionis, Exclusive License Agreement, Bicycle, Targeted Oligonucleotide Therapeutics, TfR1 Bicycle Technology
Hologic Receives CE Mark to Use Saliva Samples with Aptima SARS-CoV-2 Test in EU
Published: July 14, 2021 | Tags: Hologic, CE Mark, Saliva Samples, Aptima SARS-CoV-2 Test, EU
Hepion Reports Results of CRV431 in P-IIa AMBITION Trial for the Treatment of NASH
Published: July 14, 2021 | Tags: Hepion, CRV431, P-IIa, AMBITION Trial, NASH
Astellas and Affinivax Present Results of ASP3772 in P-II Study for Streptococcus Pneumoniae
Published: July 13, 2021 | Tags: Astellas, Affinivax, ASP3772, P-II, Study, Streptococcus pneumoniae
Hutchmed Reports First Commercial Sale of Orpathys (savolitinib) in China
Published: July 13, 2021 | Tags: Hutchmed, First Commercial Sale, Orpathys, savolitinib, China
Published: July 13, 2021 | Tags: Janssen, Darzalex Faspro, daratumumab, hyaluronidase-fihj, Pomalidomide, Dexamethasone, US, FDA, Approval, Multiple Myeloma
Menagen Signs a Commercialization Agreement with CKD for Biosimilar Darbepotein Alfa
Published: July 13, 2021 | Tags: Menagen, Commercialization Agreement, CKD, Biosimilar Darbepotein Alfa
Biogen Signs a License Agreement with Innocare for Orelabrutinib to Treat Multiple Sclerosis
Published: July 13, 2021 | Tags: Biogen, License Agreement, Innocare, Orelabrutinib, Multiple Sclerosis
Novo Nordisk to Acquire Prothena’s ATTR Amyloidosis Program for ~$1.2B
Published: July 13, 2021 | Tags: Novo Nordisk, Acquire, Prothena, ATTR Amyloidosis Programme, $1.2B
Published: July 12, 2021 | Tags: Janssen, Stelara, ustekinumab, P-lll, UNIFI LTE Study, Active Ulcerative Colitis
Published: July 12, 2021 | Tags: Galapagos, P-III, SELECTION Trials, Filgotinib, Ulcerative Colitis, UC
Published: July 12, 2021 | Tags: Innovent, P-I, CIBI323A101 Study, IBI323, Advanced Malignant Tumors
Published: July 12, 2021 | Tags: Astellas, Seagen, Padcev, enfortumab vedotin-ejfv, US, FDA, Regular Approval, Locally Advanced, Metastatic Urothelial Cancer
Published: July 12, 2021 | Tags: Takeda, Takhzyro, lanadelumab, P-III, HELP Study, Open-Label Extension, Hereditary Angioedema Attacks, EAACI 2021
Published: July 12, 2021 | Tags: Bayer, Kerendia, finerenone, US, FDA, Approval, Chronic Kidney Disease, Type 2 Diabetes
Related Post: PharmaShots Weekly Snapshots (July 05 – 09, 2021)
The post PharmaShots Weekly Snapshots (July 12 – 16, 2021) first appeared on PharmaShots.